These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30854738)

  • 21. Introducing Glycolinkers for the Functionalization of Cytotoxic Drugs and Applications in Antibody-Drug Conjugation Chemistry.
    Ekholm FS; Pynnönen H; Vilkman A; Pitkänen V; Helin J; Saarinen J; Satomaa T
    ChemMedChem; 2016 Nov; 11(22):2501-2505. PubMed ID: 27786414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel site-specific chemical conjugation of IgG antibodies by affinity peptide for immunoassays.
    Mori S; Abe A; Ishikawa N; Rafique A; Ito Y
    J Biochem; 2021 Feb; 169(1):35-42. PubMed ID: 32706869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Purification Strategy Utilizing Hydrophobic Interaction Chromatography to Obtain Homogeneous Species from a Site-Specific Antibody Drug Conjugate Produced by AJICAP™ First Generation.
    Matsuda Y; Leung M; Okuzumi T; Mendelsohn B
    Antibodies (Basel); 2020 May; 9(2):. PubMed ID: 32443479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computationally designed antibody-drug conjugates self-assembled via affinity ligands.
    Gupta N; Ansari A; Dhoke GV; Chilamari M; Sivaccumar J; Kumari S; Chatterjee S; Goyal R; Dutta PK; Samarla M; Mukherjee M; Sarkar A; Mandal SK; Rai V; Biswas G; Sengupta A; Roy S; Roy M; Sengupta S
    Nat Biomed Eng; 2019 Nov; 3(11):917-929. PubMed ID: 31686001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a High-Affinity Antibody-Binding Peptide for Site-Specific Modification.
    Muguruma K; Osawa R; Fukuda A; Ishikawa N; Fujita K; Taguchi A; Takayama K; Taniguchi A; Ito Y; Hayashi Y
    ChemMedChem; 2021 Jun; 16(11):1813-1820. PubMed ID: 33594831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Native-MS Analysis of Monoclonal Antibody Conjugates by Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.
    Campuzano IDG; Netirojjanakul C; Nshanian M; Lippens JL; Kilgour DPA; Van Orden S; Loo JA
    Anal Chem; 2018 Jan; 90(1):745-751. PubMed ID: 29193956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring alternative antibody scaffolds: Antibody fragments and antibody mimics for targeted drug delivery.
    Richards DA
    Drug Discov Today Technol; 2018 Dec; 30():35-46. PubMed ID: 30553519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and Properties of Valine-Alanine based Antibody-Drug Conjugates with Monomethyl Auristatin E as the Potent Payload.
    Wang Y; Fan S; Zhong W; Zhou X; Li S
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28841157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disulfide Modified IgG1: An Investigation of Biophysical Profile and Clinically Relevant Fc Interactions.
    Bahou C; Love EA; Leonard S; Spears RJ; Maruani A; Armour K; Baker JR; Chudasama V
    Bioconjug Chem; 2019 Apr; 30(4):1048-1054. PubMed ID: 30855134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Site-Specifically Labeled Immunoconjugates for Molecular Imaging--Part 2: Peptide Tags and Unnatural Amino Acids.
    Adumeau P; Sharma SK; Brent C; Zeglis BM
    Mol Imaging Biol; 2016 Apr; 18(2):153-65. PubMed ID: 26754791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody-Drug Conjugates Using Click Cycloaddition Chemistry.
    VanBrunt MP; Shanebeck K; Caldwell Z; Johnson J; Thompson P; Martin T; Dong H; Li G; Xu H; D'Hooge F; Masterson L; Bariola P; Tiberghien A; Ezeadi E; Williams DG; Hartley JA; Howard PW; Grabstein KH; Bowen MA; Marelli M
    Bioconjug Chem; 2015 Nov; 26(11):2249-60. PubMed ID: 26332743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of trisulfide modification of antibodies on the properties of antibody-drug conjugates manufactured using thiol chemistry.
    Liu R; Chen X; Dushime J; Bogalhas M; Lazar AC; Ryll T; Wang L
    MAbs; 2017 Apr; 9(3):490-497. PubMed ID: 28136017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development, Optimization, and Structural Characterization of an Efficient Peptide-Based Photoaffinity Cross-Linking Reaction for Generation of Homogeneous Conjugates from Wild-Type Antibodies.
    Vance N; Zacharias N; Ultsch M; Li G; Fourie A; Liu P; LaFrance-Vanasse J; Ernst JA; Sandoval W; Kozak KR; Phillips G; Wang W; Sadowsky J
    Bioconjug Chem; 2019 Jan; 30(1):148-160. PubMed ID: 30566343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptide-Drug Conjugate: A Novel Drug Design Approach.
    Ma L; Wang C; He Z; Cheng B; Zheng L; Huang K
    Curr Med Chem; 2017; 24(31):3373-3396. PubMed ID: 28393694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current methods for the synthesis of homogeneous antibody-drug conjugates.
    Sochaj AM; Świderska KW; Otlewski J
    Biotechnol Adv; 2015 Nov; 33(6 Pt 1):775-84. PubMed ID: 25981886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SpyLigase-Catalyzed Modification of Antibodies.
    Siegmund V; Piater B; Fischer F; Kolmar H
    Methods Mol Biol; 2019; 2012():171-192. PubMed ID: 31161509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of in vivo drug load distribution of cysteine-linked antibody-drug conjugates using microscale liquid chromatography mass spectrometry.
    Hengel SM; Sanderson R; Valliere-Douglass J; Nicholas N; Leiske C; Alley SC
    Anal Chem; 2014 Apr; 86(7):3420-5. PubMed ID: 24576206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thiolation of Q295: Site-Specific Conjugation of Hydrophobic Payloads without the Need for Genetic Engineering.
    Benjamin SR; Jackson CP; Fang S; Carlson DP; Guo Z; Tumey LN
    Mol Pharm; 2019 Jun; 16(6):2795-2807. PubMed ID: 31067063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing Lysosomal Activation of Antibody-Drug Conjugates (ADCs) by Incorporation of Novel Cleavable Dipeptide Linkers.
    Salomon PL; Reid EE; Archer KE; Harris L; Maloney EK; Wilhelm AJ; Miller ML; Chari RVJ; Keating TA; Singh R
    Mol Pharm; 2019 Dec; 16(12):4817-4825. PubMed ID: 31609629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding and functional profiling of antibody mutants guides selection of optimal candidates as antibody drug conjugates.
    Zwaagstra JC; Sulea T; Baardsnes J; Radinovic S; Cepero-Donates Y; Robert A; O'Connor-McCourt MD; Tikhomirov IA; Jaramillo ML
    PLoS One; 2019; 14(12):e0226593. PubMed ID: 31891584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.